BASi 3Q Revenues: $6.0 million (+3%) 3Q Loss: $75.0 million (earnings were $221 million 3Q17) YTD Revenues: $17.4 million (-5%) YTD Earnings: $6.0 million (earnings were $655 million YTD17) Comments: Service revenue in the quarter decreased 2% to $4.9 million. Preclinical services revenues and bioanalytical revenues increased $204k and $30k, respectively, due to a more favorable mix of studies in the quarter. Other laboratory services revenues were negatively impacted by lower pharmaceutica...